Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1997-12-23
1999-11-16
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242821, 4352531, A61K 3904, A61K 4500, A61K 3574
Patent
active
059852879
ABSTRACT:
The present invention provides polypeptides comprising an immunogenic portion of a M. vaccae protein and DNA molecules encoding such polypeptides, together with methods for their use in the diagnosis and treatment of mycobacterial infection. Methods for enhancing the immune response to an antigen including administration of M. vaccae culture filtrate or delipidated M. vaccae cells are also provided.
REFERENCES:
patent: 3956481 (1976-05-01), Jolles et al.
patent: 4036953 (1977-07-01), Adam et al.
patent: 4716038 (1987-12-01), Stanford et al.
patent: 4724144 (1988-02-01), Rook et al.
patent: 5599545 (1997-02-01), Stanford et al.
patent: 5833996 (1998-11-01), Stanford et al.
I.J. Hiu, "The Adjuvant Active Fraction of Delipidated Mycobacteria", Nature, vol. 267, pp. 708-709, 1977.
I.J. Hiu, "Adjuvanticity and Strains of Mycobacteria" Japan J. Exp. Med,. vol. 50, pp. 183-187, 1980.
S.J. Thompson et al., "Modulation of Pristane-Induced Arthritis by Mycobacterial Antigens", Autoimmunity, vol. 11, pp. 35-43, 1991.
C. Abou-Zeid et al. "Induction of a Type 1 Immune Response to a Recombinant Antigen from Mycobacterium tuberculosis Expressed in Mycobacterium vaccae", Infect. Immun. vol. 65, pp. 1856-1862, 1997.
Meyer et al. "Biologically Active Components from Mycobacterial Cell Walls. III. Production of Experimental Allergic Encephalomyelitis in Guinea-Pigs", Immunology, vol. 28, pp. 219-229, 1975.
Kobatake et al., Agric. Biol. Chem., vol. 51, pp. 691-697, 1987.
Navalkar et al. "Antigen Evaluation of Mycobacterium vaccae in Relation to Mycobacterium leprae" Int. J. Leprosy, vol. 48, pp. 388-396, 1980.
Hunter et al. "Isolation and Characterization of the Highly Immunogenic Cell Wall-Associated Protein of Mycobacterium leprae" Jnl. Immun. vol. 142, pp. 2864-2872, 1989.
Melancon-Kaplan et al "Immunological Significance of Mycobacterium leprae Cell Walls" Proc. Natl. Acad. USA, vol. 85, pp. 1917-1921, 1988.
R.G. White et al., "Correlation of Adjuvant Activity and Chemical Structure of Wax D Fractions of Mycobacteria," Immunology 7, pp. 158-171, 1964.
R.G. White, "Characterization of Microbacterial Components of Adjuvant Mixtures," Symposium Series Immunobiol. Standard 6, pp. 49-58, 1967.
R.G. White et al., The Influence of Components of M. Tuberculosis and other Mycobacteria upon Antibody Production to Ovalbumin, Immunology I, pp. 54-66, 1958.
Skinner, Immunization with Heat-Killed Mycobacterium vaccae Stimulates CD8.sup.+ Cytotoxic T Cells Specific for Macrophages Infected with Mycobacterium tuberculosis, Infection and Immunity 65:11, 4525-4530, 1997.
Prestidge Ross
Skinner Margot
Tan Paul
Genesis Research and Development Corporation Limited
Mosher Mary E.
Sleath Janet
Speckman Ann W.
LandOfFree
Compounds and methods for treatment and diagnosis of mycobacteri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for treatment and diagnosis of mycobacteri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for treatment and diagnosis of mycobacteri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320747